Some previous studies that did not distinguish the contribution of particular apoE species have indicated that CSF apoE levels in AD patients are increased [35], also at follow-up [36], but many studies addressing total CSF apoE levels are inconclusive and found no clear association with the AD condition or APOE genotype [20–22]. This evidence concerns the gene APOE and Alzheimer disease.